Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Managed Care
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Managed Care
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
T. Marron
CIO 2021-23 Propensity–Score-Matched Evaluation of Efficacy and Safety of TACE With Nivolumab Vs Nivolumab Monotherapy
Purpose: To assess the efficacy and safety of immune checkpoint inhibition (ICI) combined with transarterial chemoembolization (TACE) versus ICI alone for hepatocellular carcinoma (HCC). ...
N. Debnath ;
V. Bishay ;
A. Fischman ;
C. Ang ;
D. Pinato ;
M. Sung ;
M. Schwartz ;
T. Marron ;
E. Kim ;
Brett Marinelli ;
Mario Cedillo ;
11/15/2021
Featured CME Course
Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes
Upcoming Events
April 3 – April 4
April 5 – April 6
April 21 – April 24
April 29 – April 30
April 30 – May 4
May 1 – May 2
May 7 – May 9
May 8 – May 10
May 14 – May 16
May 19 – May 21
See Full Calendar